Recommendations for the Novavax COVID-19 Vaccine Primary Series in Adults Ages 18 Years and Older
The fully captioned video and edited transcript will be posted within the next few days.
Click here to view the recording with the integrated audio transcript using the password below.
Password: 9r+6G%U8
“This content and conclusions are those of the author and presenter and do not necessarily represent the views of, nor should any endorsements be inferred by, the Centers for Disease Control and Prevention.”
This COCA Call will be held on Friday, March 27, 2020
= Overview
COVID-19 vaccination provides protection against serious illness and outcomes associated with COVID-19, including emergency department or urgent care visits, hospitalizations, and death. The Novavax COVID-19 vaccine is the first COVID-19 protein subunit vaccine recommended for use in the United States that is built on a familiar type of vaccine technology. Other protein subunit vaccines have been used for more than 30 years in the United States, including for hepatitis B, HPV, and acellular pertussis (whooping cough) vaccines. During this COCA Call, presenters will discuss CDC’s new guidance on the Novavax COVID-19 vaccine for adults ages 18 years and older, including adults who are moderately or severely immunocompromised.
Presenters
Evelyn Twentyman, MD, MPH
Lead, Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Elisha Hall, PhD, RD
Lead, Clinical Guidelines Vaccine Policy Unit
COVID-19 Response
Centers for Disease Control and Prevention
Chris Duggar, MPH
Lead, COVID Vaccine Unit
COVID-19 Response
Centers for Disease Control and Prevention
Tanya Myers, PhD, MSc
Co-Lead, v-safe Team
COVID-19 Immunization Safety Unit
COVID-19 Response
Centers for Disease Control and Prevention
When:
Thursday, July 28, 2022,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1612728470
Passcode: 663869
Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590
One-tap mobile:
US: +16692545252,,1612728470#,,,,*663869# or +16468287666,,1612728470#,,,,*663869#
Webinar ID: 161 272 8470
Add to Calendar
Due to the high demand we anticipate for this COCA Call, we encourage participants to consider viewing on Facebook. To see the call live, please click on COCA’s Facebook Page.
When:
Thursday, June 16, 2022,
2:00 PM – 3:00 PM ET
Webinar Link:
https://www.zoomgov.com/j/1603960029
Passcode: 308026
Dial In:
US: +1 669 254 5252
or +1 646 828 7666
or +1 551 285 1373
or +1 669 216 1590
One-tap mobile:
US: +16692545252,,1603960029#,,,,*308026# or +16468287666,,1603960029#,,,,*308026#
Webinar ID: 160 396 0029
Add to CalendarTo receive continuing education (CE) for WC4520-072822 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Recommendations for the Novavax COVID-19 Primary Series in Adults Ages 18 and Older, Thursday, July 28, 2022, please visit TCEO and follow these 9 Simple Steps by Monday, August 29, 2022.
To receive continuing education (CE) for WD4520-072822 – Clinician Outreach and Communication Activity (COCA) Calls/Webinars – Recommendations for the Novavax COVID-19 Primary Series in Adults Ages 18 and Older, Thursday, July 28, 2022, (Web on Demand), please visit TCEO and follow these 9 Simple Steps between Tuesday, August 30, 2022, and Friday, August 30, 2024.
In support of improving patient care, the Centers for Disease Control and Prevention is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: The Centers for Disease Control and Prevention designates this activity for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
AAPA CME: The Centers for Disease Control and Prevention has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1 AAPA Category 1 CME credits. Approval is valid until 12/13/2023. PAs should only claim credit commensurate with the extent of their participation
CNE: The Centers for Disease Control and Prevention designates this activity for 1 nursing contact hours.
CPE: The Centers for Disease Control and Prevention designated this (Knowledge-based) event for pharmacists to receive 0.1 CEUs in pharmacy education. The Universal Activity Number is JA4008229-0000-22-102-L04-P and enduring is JA4008229-0000-22-103-H04-P.
Once credit is claimed, an unofficial statement of credit is immediately available on TCEOnline. Official credit will be uploaded within 60 days on the NABP/CPE Monitor.
CEU: The Centers for Disease Control and Prevention is authorized by IACET to offer 0.1 CEU’s for this program.
CECH: Sponsored by the Centers for Disease Control and Prevention, a designated provider of continuing education contact hours (CECH) in health education by the National Commission for Health Education Credentialing, Inc. This program is designated for Certified Health Education Specialists (CHES®) and/or Master Certified Health Education Specialists (MCHES®) to receive up to 1.0 total Category I continuing education contact hours. Maximum advanced level continuing education contact hours available are 1. Continuing Competency credits available are 1. CDC provider number 98614.
AAVSB/RACE: This program was reviewed and approved by the AAVSB RACE program for 1.0 hours of continuing education. Participants should be aware that some boards have limitations on the number of hours accepted in certain categories and/or restrictions on certain methods of delivery of continuing education. Please contact the AAVSB RACE program at race@aavsb.org if you have any comments/concerns regarding this program’s validity or relevancy to the veterinary profession.
For Certified Public Health Professionals (CPH): The Centers for Disease Control and Prevention is a pre-approved provider of Certified in Public Health (CPH) recertification credits and is authorized to offer 1 CPH recertification credits for this program.
DISCLOSURE: In compliance with continuing education requirements, all planners and presenters must disclose all financial relationships, in any amount, with ineligible companies over the previous 24 months as well as any use of unlabeled product(s) or products under investigational use.
CDC, our planners, and presenters wish to disclose they have no financial relationship(s) with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Presentations will not include any discussion of the unlabeled use of a product or a product under investigational use with the exception of Dr. Hall’s and Dr. Twentyman’s discussion of vaccine use under Emergency Use Authorization or Emergency Use Instruction.
CDC did not accept financial or in-kind support from ineligible companies for this continuing education activity.
Sign up to receive COCA Call Announcements, COCA Newsletters and other COCA resources by entering your email address: